TrialBMC cancer2021

Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).

P Grivas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.